Novel perspectives of neural stem cell differentiation: From neurotransmitters to therapeutics
✍ Scribed by Cleber A. Trujillo; Telma T. Schwindt; Antonio H. Martins; Janaína M. Alves; Luiz Eugênio Mello; Henning Ulrich
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 486 KB
- Volume
- 75A
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Temporal analysis in gene expression during differentiation of neural stem cells (NSCs) was performed by using in‐house microarrays composed of 10,368 genes. The changes in mRNA level were measured during differentiation day 1, 2, 3, 6, 12, and 15. Out of 10,368 genes analyzed, 259 gene
## Abstract To investigate the effect of estrogen on neuronal differentiation, especially on dopaminergic (DA) neurons, human neural stem cells (NSCs) were differentiated in the presence of 17β‐estradiol. NSCs gave rise to tyrosine hydroxylase (TH)‐positive neurons in vitro, the proportion of which
## Abstract Cell therapies in animal models of neurobehavioral defects are normally derived from neural stem cells (NSC) of the developing cortex. However, the clinical feasibility of NSC therapies would be greatly improved by deriving transplanted cells and from a tissue culture source that is sel
## Abstract Establishment of an in vitro model of human cholinergic neurons would be highly desirable for understanding and developing treatment for Alzheimer's and motoneuron diseases. Previously we reported that the combination of basic fibroblast growth factor (bFGF), heparin, and laminin direct